174 related articles for article (PubMed ID: 19363679)
1. Ulnar artery vasculopathy in systemic sclerosis.
Park JH; Sung YK; Bae SC; Song SY; Seo HS; Jun JB
Rheumatol Int; 2009 Jul; 29(9):1081-6. PubMed ID: 19363679
[TBL] [Abstract][Full Text] [Related]
2. Ulnar artery involvement in systemic sclerosis (scleroderma).
Taylor MH; McFadden JA; Bolster MB; Silver RM
J Rheumatol; 2002 Jan; 29(1):102-6. PubMed ID: 11824945
[TBL] [Abstract][Full Text] [Related]
3. [Macrovascular complications of systemic sclerosis: Prospective descriptive Doppler ultrasound study in 20 patients].
Doutrelon C; Skopinski S; Boulon C; Constans J
J Mal Vasc; 2016 Jul; 41(4):253-9. PubMed ID: 27174391
[TBL] [Abstract][Full Text] [Related]
4. Arteriographic evaluation of vascular changes of the extremities in patients with systemic sclerosis.
Hasegawa M; Nagai Y; Tamura A; Ishikawa O
Br J Dermatol; 2006 Dec; 155(6):1159-64. PubMed ID: 17107383
[TBL] [Abstract][Full Text] [Related]
5. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
Serri J; Legré R; Veit V; Guardia C; Gay AM
Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
[TBL] [Abstract][Full Text] [Related]
6. Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis.
Galluccio F; Matucci-Cerinic M
Autoimmun Rev; 2011 Mar; 10(5):241-3. PubMed ID: 20863907
[TBL] [Abstract][Full Text] [Related]
7. Ascorbic acid does not improve endothelium-dependent flow-mediated dilatation of the brachial artery in patients with Raynaud's phenomenon secondary to systemic sclerosis.
Mavrikakis ME; Lekakis JP; Papamichael CM; Stamatelopoulos KS; Kostopoulos ChC; Stamatelopoulos SF
Int J Vitam Nutr Res; 2003 Feb; 73(1):3-7. PubMed ID: 12690904
[TBL] [Abstract][Full Text] [Related]
8. Evidence of macro- and micro-angiopathy in scleroderma: An integrated approach combining 22-MHz power Doppler ultrasonography and video-capillaroscopy.
Schioppo T; Orenti A; Boracchi P; De Lucia O; Murgo A; Ingegnoli F
Microvasc Res; 2019 Mar; 122():125-130. PubMed ID: 29981761
[TBL] [Abstract][Full Text] [Related]
9. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
Gore J; Silver R
Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
[No Abstract] [Full Text] [Related]
10. On surgical microarteriolysis for treatment of Raynaud's phenomenon in scleroderma.
van den Broeck D; Coessens BC; Peretz A
Br J Rheumatol; 1997 Jun; 36(6):706-7. PubMed ID: 9236686
[No Abstract] [Full Text] [Related]
11. Raynaud's phenomenon.
Devgire V; Hughes M
Br J Hosp Med (Lond); 2019 Nov; 80(11):658-664. PubMed ID: 31707892
[TBL] [Abstract][Full Text] [Related]
12. Hypothenar hammer syndrome followed by systemic sclerosis.
Lambert M; Hatron PY; Hachulla E; Devulder B
J Rheumatol; 2000 Oct; 27(10):2516-7. PubMed ID: 11036855
[TBL] [Abstract][Full Text] [Related]
13. Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosis.
Meyrick Thomas RH; Rademaker M; Grimes SM; MacKay A; Kovacs IB; Cook ED; Bowcock SM; Kirby JD
Br J Dermatol; 1987 Aug; 117(2):237-41. PubMed ID: 3307894
[TBL] [Abstract][Full Text] [Related]
14. Large vessel occlusive disease associated with CREST syndrome and scleroderma.
Youssef P; Englert H; Bertouch J
Ann Rheum Dis; 1993 Jun; 52(6):464-6. PubMed ID: 8323401
[TBL] [Abstract][Full Text] [Related]
15. Arterial vasculopathy in systemic sclerosis: computerized tomography (CT) angiographic features of macrovascular and microvascular upper limbs arteries.
Emad Y; Al-Sherbeni H; Ragab Y; Abo-El-Youn I; El-Shaarawy N; Nassar DY; Fathy A; Al-Hanafi H; Rasker JJ
Joint Bone Spine; 2014 Oct; 81(5):433-7. PubMed ID: 24956984
[TBL] [Abstract][Full Text] [Related]
16. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
Colakoğlu M; Cobankara V; Akpolat T
Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
[TBL] [Abstract][Full Text] [Related]
17. MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study.
Hughes M; Di Donato S; Gjeloshi K; Abignano G; Danzo F; Lettieri G; De Lorenzis E; Bertham D; O'Connor P; Kubassova O; Dehmeshki J; Del Galdo F
Lancet Rheumatol; 2023 Oct; 5(10):e611-e621. PubMed ID: 38251485
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis patients with botulinum toxin B injection: Assessment of peripheral vascular disorder by angiography and dermoscopic image of nail fold capillary.
Motegi SI; Sekiguchi A; Saito S; Ishibuchi H; Kishi C; Yasuda M; Ishikawa O
J Dermatol; 2018 Mar; 45(3):349-352. PubMed ID: 29164658
[TBL] [Abstract][Full Text] [Related]
19. Raynaud's phenomenon and systemic sclerosis.
Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Botulinum Toxin B Injection for Raynaud's Phenomenon and Digital Ulcers in Patients with Systemic Sclerosis.
Motegi SI; Uehara A; Yamada K; Sekiguchi A; Fujiwara C; Toki S; Date Y; Nakamura T; Ishikawa O
Acta Derm Venereol; 2017 Jul; 97(7):843-850. PubMed ID: 28358168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
